β-受体阻滞剂对脓毒症早期急性低氧性呼吸衰竭患者的保护作用

易玲娴; 吴柳琳; 张慧; 郭金玲; 杨阳; 石红燕; 周文静; 胡美

doi:10.13201/j.issn.1009-5918.2020.10.006

β-受体阻滞剂对脓毒症早期急性低氧性呼吸衰竭患者的保护作用

- 中国人民解放军战略支援部队特色医学中心重症医学科(北京, 100101)

详细信息

通讯作者: 胡美,E-mail:clinical2019m@163.com

中图分类号: R459.7

收稿日期: 2020-08-02

Protective effects of β-blockers on patients with acute hypoxemic respiratory failure in the early sepsis

- Department of Critical Care Medicine, PLA Strategic Support Force Characteristic Medical Center, Beijing, 100101, China

More Information

Corresponding author: HU Mei, E-mail: clinical2019m@163.com

Received Date: 02 August 2020

摘要

摘要: 目的:探索β受体阻滞剂对脓毒症早期急性低氧性呼吸衰竭(AHRF)患者临床特征及结局的影响。方法:回顾性收集2015-01-01-2019-12-31期间所有入住中国人民解放军战略支援部队特色医学中心重症医学科的脓毒症患者数据,根据入院后有无使用β受体阻滞剂分为β受体阻滞剂组和non-β受体阻滞剂组,比较两组患者血气指标、生化指标、循环状态以及机械通气天数、ICU住院天数、28 d存活情况。结果:总共有105例脓毒症早期AHRF患者纳入研究,其中β受体阻滞剂组47例,non-β受体阻滞剂组58例。与non-β受体阻滞剂组相比,β受体阻滞剂可以改善PO₂和氧合指数,降低乳酸水平,增加淋巴细胞数量,减少血管活性药物的使用(P<0.05)。并且β受体阻滞剂可明显减少脓毒症早期AHRF患者的机械通气天数,ICU住院天数和28 d病死率(P<0.05)。多因素COX回归分析显示,β受体阻滞剂可以降低脓毒症早期AHRF患者的死亡风险(OR=0.781,95%CI:0.726~0.841,P<0.05),而高乳酸(OR=1.198,95%CI:1.178~1.218,P<0.01)、高SOFA评分(OR=1.222,95%CI:1.207~1.238,P<0.01)以及男性(OR=1.676,95%CI:1.559~1.806,P<0.01)可增加28 d病死率。结论:β受体阻滞剂是脓毒症早期AHRF患者的保护因素,而高乳酸、高SOFA评分以及男性是危险因素。
- β受体阻滞剂 /
- 脓毒症 /
- 急性呼吸衰竭 /
- SOFA评分 /
- 病死率
Abstract: Objective:To explore the effect of β-blockers on the clinical characteristics and outcome of patients with acute hypoxemic respiratory failure(AHRF) in early sepsis. Method:The data were retrospectively collected from sepsis patients who were admitted to the Department of Critical Medicine of PLA Strategic Support Force Characteristic Medical Center from January 1, 2015 to December 31, 2019. The patients were divided into two groups, β-blocker group and non-β-blocker group, according to the use of β-blockers after admission. The blood gas indexes, biochemical indexes, circulatory state indexes, days of mechanical ventilation, length of ICU stay, and 28-day survival were compared between the two groups. Result:A total of 105 patients with AHRF in the early sepsis were enrolled in the study, including 47 patients in the β-blocker group and 58 patients in the non-β-blocker group. Compared with non-β-blocker group, β-blockers group improved PO₂ and oxygenation index, decreased the level of lactic acid, increased the number of lymphocytes and reduced the dose of vasoactive drugs(P<0.05). The days of mechanical ventilation, length of ICU stay, and 28-day mortality of AHRF patients in the early sepsis significantly reduced in the β-blocker group(P<0.05). In multivariate COX regression analysis, β-blockers reduced the risk of death in AHRF patients with early sepsis(OR=0.781, 95%CI:0.726-0.841, P<0.05), while high lactic acid level(OR=1.198, 95%CI:1.178-1.218, P<0.01), high SOFA score(OR=1.222, 95%CI:1.207-1.238, P<0.01) and male(OR=1.676, 95%CI:1.559-1.806, P<0.01) increased 28-day mortality significantly.Conclusion:β-blockers were protective for AHRF patients in early sepsis, while high lactic acid level, high SOFA score and male were risk factors.
- β-blockers /
- sepsis /
- acute respiratory failure /
- SOFA score /
- mortality

HTML全文

参考文献(24)

[1]	Rudd KE,Johnson SC,Agesa KM,et al.Global,regional,and national sepsis incidence and mortality,1990-2017:analysis for the Global Burden of Disease Study[J].Lancet,2020,395(10219):200-211.
[2]	Levy MM,Evans LE,Rhodes A.The Surviving Sepsis Campaign Bundle:2018 Update[J].Crit Care Med,2018,46(6):997-1000.
[3]	Rhodes A,Evans LE,Alhazzani W,et al.Surviving Sepsis Campaign:International Guidelines for Management of Sepsis and Septic Shock:2016[J].Crit Care Med,2017,45(3):486-552.
[4]	Van der Jagt M,Miranda DR.Beta-blockers in intensive care medicine:potential benefit in acute brain injury and acute respiratory distress syndrome[J].Recent Pat Cardiovasc Drug Discov,2012,7(2):141-151.
[5]	Anoop UR,Kavita V.Pulmonary Edema in COVID19-A Neural Hypothesis[J].ACS Chem.Neurosci,2020,11,2048-2050.
[6]	Zhang L,Nie Y,Zheng Y,et al.Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats[J].Pancreatology,2016,16(5):726-32.
[7]	Auriemma CL,Zhuo H,Delucchi K,et al.Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis[J].Intensive Care Med,2020,46(6):1222-1231.
[8]	Liu P,Wu Q,Tang Y,et al.The influence of esmolol on septic shock and sepsis:A meta-analysis of randomized controlled studies[J].Am J Emerg Med,2018,36(3):470-474.
[9]	Coppola S,Froio S,Chiumello D.beta-blockers in critically ill patients:from physiology to clinical evidence[J].Crit Care,2015,19:119.
[10]	Pemberton P,Veenith T,Snelson C,et al.Is It Time to Beta Block the Septic Patient?[J].Biomed Res Int,2015,2015:424308.
[11]	武冬,王顺达,符莹莹,等.艾司洛尔对脓毒症急性肺损伤大鼠肺泡炎症因子及氧化应激蛋白的调控研究[J].中南医学科学杂志,2019,47(4):363-366.
[12]	李霞,王姣.酒石酸美托洛尔对脂多糖致急性肺损伤小鼠的炎症及凋亡的影响[J].医学理论与实践,2020,33(4):638-639.
[13]	李杜鹏,赵妮,罗书航,等.艾司洛尔对脓毒症大鼠肺脏保护作用的实验研究[J].中华急诊医学杂志,2018,27(1):78-84.
[14]	Singer M,Deutschman CS,Seymour CW,et al.The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)[J].JAMA,2016,315(8):801-810.
[15]	Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,2013,41(2):580-637.
[16]	Brown RM,Wang L,Coston TD,et al.Balanced Crystalloids versus Saline in Sepsis.A Secondary Analysis of the SMART Clinical Trial[J].Am J Respir Crit Care Med,2019,200(12):1487-1495.
[17]	Gennaro P,Graziamaria C,Nicola F.Adrenergic Nervous System and Hemostasis[J].J Hematol Thrombo Dis,2014,2:e108.
[18]	Chignalia AZ,Weinberg G,Dull RO,Norepinephrine Induces Lung Microvascular Endothelial Cell Death by NADPH Oxidase-Dependent Activation of Caspase-3[J].Oxid Med Cell Longev,2020,2020:2563764.
[19]	Richter T,Bergmann R,Pietzsch J,et al.Effects of pulmonary acid aspiration on the regional pulmonary blood flow within the first hour after injury:An observational study in rats[J].Clin Hemorheol Microcirc,2015,60(2):253-262.
[20]	Matsuishi Y,Jesmin S,Kawano S,et al.Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1[J].Life Sci 2016,166:27-33.
[21]	Suzuki T,Inoue K,Igarashi T,et al.Beta-Blocker Therapy Preserves Normal Splenic T-Lymphocyte Numbers Reduced in Proportion to Sepsis Severity in a Sepsis Model[J].Crit Care Res Pract,2019,2019:8157482.
[22]	Asai N,Shiota A,Ohashi W,et al.The SOFA score could predict the severity and prognosis of infective endocarditis[J].J Infect Chemother 2019,25(12):965-971.
[23]	Wang Y,Wang D,Fu J,et al.Predictive value of SOFA,qSOFA score and traditional evaluation index on sepsis prognosis[J].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,2017,29(8):700-704.
[24]	Bösch F,Angele MK,Chaudry IH.Gender differences in trauma,shock and sepsis[J].Mil Med Res,2018,5(1):35.